Fi3 Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fi3 Financial Advisors's PFE Position: Q2 2026 in Review
Fi3 Financial Advisors reduced its Pfizer (PFE) stake by 43% in Q2 2026, selling an estimated $139K and leaving 7,078 shares worth $958K. The position accounts for 0.23% of the portfolio, ranked #47.
Fi3 Financial Advisors first reported a position in PFE in Q4 2022 and has held it in 9 quarters since. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fi3 Financial Advisors held 7,078 shares of Pfizer worth $958K as of Q2 2026.
- Fi3 Financial Advisors sold 5,313 Pfizer shares in Q2 2026, an estimated $139K.
- Pfizer made up 0.23% of Fi3 Financial Advisors's portfolio in Q2 2026, its #47 holding.
- Fi3 Financial Advisors first reported a position in Pfizer in Q4 2022 and has held it in 9 quarters since.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fi3 Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.